Intuitive Surgical (NASDAQ:ISRG) Stock Rating Lowered by Zacks Research

Intuitive Surgical (NASDAQ:ISRG) was downgraded by Zacks Research from a “strong-buy” rating to a “hold” rating in a note issued to investors on Wednesday,Zacks.com reports.

Other equities analysts also recently issued reports about the company. Wall Street Zen upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Saturday, January 17th. Mizuho set a $575.00 price objective on Intuitive Surgical in a research note on Wednesday, October 22nd. Hsbc Global Res upgraded shares of Intuitive Surgical to a “strong-buy” rating in a research note on Thursday, October 23rd. The Goldman Sachs Group reaffirmed a “buy” rating and issued a $714.00 price target on shares of Intuitive Surgical in a report on Friday, January 9th. Finally, Evercore ISI set a $580.00 target price on Intuitive Surgical in a research note on Monday, January 5th. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, nine have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $621.83.

Intuitive Surgical Stock Down 0.2%

Shares of Intuitive Surgical stock traded down $0.96 on Wednesday, hitting $524.85. 582,776 shares of the company’s stock traded hands, compared to its average volume of 1,948,497. The stock has a market cap of $188.15 billion, a P/E ratio of 69.34, a PEG ratio of 4.26 and a beta of 1.67. The firm’s 50-day moving average is $562.83 and its 200 day moving average is $511.86. Intuitive Surgical has a 52-week low of $425.00 and a 52-week high of $609.08.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The firm had revenue of $2.87 billion for the quarter, compared to analysts’ expectations of $2.72 billion. During the same period in the prior year, the company posted $2.21 earnings per share. The firm’s quarterly revenue was up 18.8% on a year-over-year basis. Equities research analysts forecast that Intuitive Surgical will post 6.43 EPS for the current year.

Insiders Place Their Bets

In related news, insider Gary S. Guthart sold 22,806 shares of the firm’s stock in a transaction that occurred on Monday, December 1st. The stock was sold at an average price of $570.89, for a total value of $13,019,717.34. Following the sale, the insider directly owned 2,694 shares in the company, valued at $1,537,977.66. This trade represents a 89.44% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Mark Brosius sold 4,500 shares of the business’s stock in a transaction on Friday, December 12th. The stock was sold at an average price of $547.36, for a total value of $2,463,120.00. Following the transaction, the senior vice president owned 907 shares of the company’s stock, valued at $496,455.52. This trade represents a 83.23% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 55,714 shares of company stock worth $31,617,799. 0.70% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the company. Riversedge Advisors LLC raised its holdings in shares of Intuitive Surgical by 1.9% in the 4th quarter. Riversedge Advisors LLC now owns 901 shares of the medical equipment provider’s stock worth $510,000 after purchasing an additional 17 shares in the last quarter. Fiduciary Financial Group LLC grew its position in Intuitive Surgical by 2.1% in the fourth quarter. Fiduciary Financial Group LLC now owns 920 shares of the medical equipment provider’s stock worth $521,000 after buying an additional 19 shares during the last quarter. Prosperity Consulting Group LLC increased its holdings in shares of Intuitive Surgical by 0.5% in the third quarter. Prosperity Consulting Group LLC now owns 4,033 shares of the medical equipment provider’s stock valued at $1,804,000 after buying an additional 19 shares in the last quarter. Rossmore Private Capital increased its holdings in shares of Intuitive Surgical by 2.0% in the third quarter. Rossmore Private Capital now owns 998 shares of the medical equipment provider’s stock valued at $446,000 after buying an additional 20 shares in the last quarter. Finally, Activest Wealth Management lifted its position in shares of Intuitive Surgical by 21.7% during the 3rd quarter. Activest Wealth Management now owns 112 shares of the medical equipment provider’s stock valued at $50,000 after acquiring an additional 20 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

More Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Q4 results beat consensus — Intuitive reported $2.53 EPS and $2.87B revenue, both topping Street estimates and showing strong procedure-driven demand for its da Vinci platform. Reuters: Intuitive Surgical beats quarterly estimates
• Positive Sentiment: Sanford C. Bernstein raised its price target to $750 and kept an Outperform — a very bullish signal that implies material upside (~42% from the $525.81 reference). Benzinga: Sanford C. Bernstein raises target
• Positive Sentiment: BTIG reaffirmed a Buy with a $616 target and other firms (William Blair, BofA mentions) reiterated bullish ratings — analyst support is amplifying demand for the stock. TipRanks: BTIG buy rating
• Neutral Sentiment: Company guidance is constructive but cautious — Intuitive expects procedure growth to slow from recent levels (midpoint guidance implies deceleration) and flags tariff headwinds that will modestly pressure gross margin in 2026. GlobeNewswire: Q4 press release
• Neutral Sentiment: Analyst commentary and longer-term writeups highlight durable growth (procedure mix, recurring consumables, new platforms like Ion and SP) but note Intuitive’s premium valuation — supporting a buy case but suggesting limited margin for disappointment. Yahoo/analysis: 5‑year outlook
• Negative Sentiment: Zacks downgraded ISRG from Strong-Buy to Hold, trimming the bullish cohort and signaling some analysts see less near-term upside despite the beat. Zacks: downgrade
• Negative Sentiment: Notable insider selling and institutional position changes highlighted by third-party trackers could worry some investors about near-term conviction among insiders and large holders. QuiverQuant: insider activity & institutional moves

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.